Scenic Biotech Joins Michael J. Fox Foundation’s LITE Program to Explore New Disease-Modifying ...
Collaboration will evaluate Scenic's first-in-class PLA2G15 inhibitor program in Parkinson's diseaseLeveraging MJFF’s LITE consortium and world-class LRRK2 biology and biomarker infrastructure to test ...
Abstract: Data imbalance is an important issue in data-driven deep-learning methodologies. In sound event detection (SED), there are two types of data imbalance issues caused by the diverse time ...
Proof-of-concept SHEPHERD study will assess SUL-238's effects on mitochondrial function in patients with Parkinson's disease.
On May 29, 2026, the U.S. District Court for the District of New Jersey found that while a certified class of performers on an adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results